NCT03523195 - Exercise Intervention After Cancer Treatment for Improving Health in Stage II-III Breast Cancer Survivors | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

April 18, 2018

Primary Completion Date

July 15, 2019

Study Completion Date

July 15, 2019

Conditions

Anatomic Stage II Breast Cancer AJCC v8Anatomic Stage IIA Breast Cancer AJCC v8Anatomic Stage IIB Breast Cancer AJCC v8Anatomic Stage III Breast Cancer AJCC v8Anatomic Stage IIIA Breast Cancer AJCC v8Anatomic Stage IIIB Breast Cancer AJCC v8Anatomic Stage IIIC Breast Cancer AJCC v8Cancer SurvivorEstrogen Receptor PositiveHER2/Neu NegativeProgesterone Receptor PositivePrognostic Stage II Breast Cancer AJCC v8Prognostic Stage IIA Breast Cancer AJCC v8Prognostic Stage IIB Breast Cancer AJCC v8Prognostic Stage III Breast Cancer AJCC v8Prognostic Stage IIIA Breast Cancer AJCC v8Prognostic Stage IIIB Breast Cancer AJCC v8Prognostic Stage IIIC Breast Cancer AJCC v8Sedentary Lifestyle

Interventions

BEHAVIORAL

Exercise Intervention

Complete exercise program

OTHER

Informational Intervention

Receive written information on healthy exercise and diet recommendations

OTHER

Laboratory Biomarker Analysis

Blood tests

DEVICE

Monitoring Device

Wear Fitbit

OTHER

Questionnaire Administration

Ancillary studies

OTHER

Physical Performance Testing

Performance of physical tests

Trial Locations (1)

98109

Fred Hutch/University of Washington Cancer Consortium, Seattle

All Listed Sponsors

collaborator

National Cancer Institute (NCI)

NIH

lead

Fred Hutchinson Cancer Center

OTHER